Director, Marketing & Communications
Keystone Symposia on Molecular & Cellular Biology
Phone: 1 970 262 2676
Keystone Symposia to Host a Free Evening Forum for the Public on Breakthroughs in Alzheimers Research Tuesday, March 4
SILVERTHORNE, CO February 28, 2014 Keystone Symposia is pleased to invite the local Summit County community to The Eileen and Paul Finkel Auditorium at Colorado Mountain College in Breckenridge on Tuesday evening, March 4 to hear three esteemed researchers discuss the work they are doing finding new ways to identify, delay or even prevent, and treat the deadly disease of Alzheimers. The hour-long free event begins at 7:00 PM.
Beginning March 2 and running for the week, Keystone Symposia is convening joint scientific research conferences at Keystone Conference Center on Alzheimers Disease (AD) and Parkinsons Disease (AD). According to Dr. David Woodland, Keystone Symposias Chief Scientific Officer, Convening the worlds leading AD and PD scientists here in Summit County next week provides an ideal opportunity to get the public in on the discussion. Given the demographics of Summit County and the fact that Alzheimers is largely a disease resulting from extended life expectancies, the event should be of great interest to members of the community.
According to the Alzheimers Association, one in three Americans will die with Alzheimers or dementia. Approximately five million Americans have Alzheimers, and it is the sixth-leading cause of death in the United States. The toll will likely only worsen as life expectancies increase.
At the community forum, the lead organizer of Keystone Symposias Alzheimers scientific conference, Dr. John Q. Trojanowski of the University of Pennsylvania, will talk about the diet and lifestyle choices we can actively make to delay and perhaps even prevent the onset of Alzheimers Disease. Dr. Trojanowski is Professor of Pathology and Laboratory Medicine at the University of Pennsylvania and Director of the NIA Alzheimers Disease Center. He pursues research on Alzheimers and Parkinsons disease, motor neuron disease, amyotrophic lateral sclerosis (ALS or Lou Gehrigs disease), frontotemporal degeneration and related disorders. He led an effort to prepare a 2009 PBS film on healthy brain aging and AD (Alzheimers Disease Facing the Facts).
Dr. David M. Holtzman of Washington University School of Medicine in St. Louis will discuss new treatment trials underway using antibodies against amyloid-β (Aβ), the molecule whose accumulation appears to initiate AD. His lab has also developed a way to monitor production and clearance of Aβ in the central nervous system of mice and humans. They have found that Aβ levels are dynamically regulated by synaptic activity and the sleep/wake cycle, leading them to theorize that sleep deprivation may contribute to AD risk. At Washington University, Dr. Holtzman is the Andrew and Gretchen Jones Professor and Head of the Department of Neurology. In addition to his laboratory, administrative and teaching duties, Dr. Holtzman is involved in clinical and research activities at the Washington University Alzheimers Disease Research Center. He has appeared on the Charlie Rose Brain Series on PBS.
Finally, Dr. Richard Mayeux of Columbia University will talk about family risk and genetic predisposition. Dr. Mayeux is Professor of Neurology, Psychiatry and Epidemiology at Columbia University as well as Neurologist-in-Chief and Chair of the Department of Neurology at New York Presbyterian Hospital. Since 1989, he has led a multi-disciplinary, population-based, epidemiological investigation of Alzheimers and related conditions.
Brief presentations at the event will be followed by audience Q&A and panel discussion.
For a flyer on this event, visit keystonesymposia.org/views/web/PDFs/Keystone_Symposia_AD_Community_Forum_Flyer.pdf
Useful Links to Learn More
To learn more about Alzheimers, retrieve the following free publications:
Alzheimers Association: 2013 Alzheimers Disease Facts and Figures
Alzheimers Association and CDC: Healthy Brain Initiative
National Institute on Aging: Preventing Alzheimers Disease:
New York Academy of Sciences: Economic Analysis of Opportunities to Accelerate Alzheimers Disease Research and Development
To find directions to the Colorado Mountain College campus in Breckenridge, visit: http://coloradomtn.edu/campuses/breckenridge_dillon/contact_map/
About Keystone Symposia on Molecular & Cellular Biology
Keystone Symposia is a nonprofit organization convening open scientific conferences that was founded as UCLA Symposia in 1972. It has been headquartered in Silverthorne, Colorado, USA since 1990 and is directed by a volunteer Board of internationally acclaimed scientists.
The organization convenes 50-60 open, international research conferences each year in diverse areas ranging from cancer and immunology to metabolic disease and neurobiology. More information on the organization and its conferences can be found at www.keystonesymposia.org and www.keystonesymposia.org/meetings, respectively.